Communiqués Aibotics Inc.

Actions

AIBT

US62846W1071

Marché Fermé - OTC Markets 20:52:52 25/09/2026			Varia. 5j.	Varia. 1 janv.
0,001000 ^USD	+11,11%		-9,09%	-60,00%

19/08	Aibotics Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
09/06	Aibotics Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

19/05	AIBotics Enters Strategic AI Partnership and Joint Venture with ARYA AI Labs to Advance Next-Generation Deterministic “World Models”	AQ
30/12/24	AIBotics Provides 2025 Update; Strengthens Position in AI, Wellness, and Robotics	AQ
04/12/23	Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million	AQ
03/05/23	Mycotopia Therapies : Non-Reliance on Previously Issued Financial Report - Form 8-K	PU
03/05/23	MYCOTOPIA THERAPIES, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	AQ
30/03/23	MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K)	AQ
22/02/23	MYCOTOPIA THERAPIES, INC. : Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
21/02/23	PSLY.com, Inc. Ei.Ventures, Inc. and Mycotopia Therapies Inc. Terminate Agreement and Plan of Merger	AQ
07/12/22	Ehave Shareholder from CEO Ben Kaplan and Corporate Update	AQ
14/11/22	MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
11/08/22	MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
23/05/22	MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
23/05/22	Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ	AQ
20/05/22	Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction	PR
19/05/22	MYCOTOPIA THERAPIES, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
19/05/22	Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction	AQ
09/05/22	Mycotopia Therapies Inc. Update on Ei.Ventures and Strategic Investments	AQ
02/05/22	Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market	AQ
14/04/22	MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K)	AQ
21/03/22	Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products	AQ
14/01/22	MYCOTOPIA THERAPIES, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
08/12/21	Ehave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. Ventures	AQ
07/12/21	Mycotopia and Ei.Ventures sign LOI to Explore Merger and Formation of PSLY.COM, a $360 Million Transaction, And Will Apply To List Shares On NASDAQ	GL
19/11/21	MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
17/11/21	Mycotopia Therapies Announces Plan to Develop Psychedelic Sublingual Tablet to Help Treat Depression	AQ